Axis Three

Axis Three Launches Groundbreaking New Surgical Simulation Software -- 'Portrait 3d', v 2.0 - beta; First Physics-Based Tissue Simulation Software for Breast Procedures

Published in Healthcare Finance, Tax and Law Weekly, November 19th, 2008

Axis Three, the leader and pioneer of surgical simulation tools for the cosmetic surgery industry, announced the launch of the Portrait 3d software product, the first simulation software based on physics-driven tissue typing. It is the first product of its type ever to be launched for the cosmetic surgery marketplace.

"Portrait 3d is the culmination of five years of development and is based purely in science," said Jim Blumel, VP of US Operations. "It represents a major advancement in the 3D surgical simulation market and significantly propels Axis Three far ahead of any competing products by leaps and bounds." The product was recently profiled on the CBS show 'The...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly

Source: Healthcare Finance, Tax and Law Weekly (2008-11-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry